Re-Medical has developed the “next generation” painkiller medication, with oral, transdermal, and injectable delivery of full-spectrum standardized formulations of cannabidiol (CBD) and/or tetrahydrocannabinol (THC) for pain related ailments. Phase 1 and Phase 2 testing of numerous cannabinoid pain … Read More
The post Hop-on Subsidiary Re-Medical is Poised for Next Generation of Pain Killers appeared first on Dagga Magazine.